All In MedTech

Device Trial Radar · NCT07193017

The Effect of BIPAP on Diaphragmatic Function

The Effects of Biphasic Positive Airway Pressure (BIPAP) Use on Diaphragm Functions in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Oct 15, 2025

Primary completion

Mar 15, 2027

Study completion Jun 15, 2027

Sponsor

Lead sponsor
Istanbul Demiroglu Bilim UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
First posted
Sep 25, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This research is designed to evaluate how long-term treatment with Bilevel Positive Airway Pressure (BiPAP) influences diaphragm function in patients with Chronic Obstructive Pulmonary Disease (COPD) who suffer from chronic hypercapnic respiratory failure. The diaphragm is the primary muscle of breathing, and its dysfunction is linked to unfavorable clinical outcomes such as higher mortality rates and frequent hospitalizations. In this prospective cohort study, COPD patients starting BiPAP therapy based on clinical indication will be monitored through repeated ultrasound assessments of diaphragm structure and function together with pulmonary function testing, respiratory muscle strength evaluation, dyspnea. The main outcome of interest is the change in diaphragm thickness in inspiration, thickness in expiration, diaphragm thickening fraction (DTF), diaphragm maximum contraction velocity and maximum relaxation velocity across a 6 weeks as a early time and 12 months for long time follow-up period. Secondary measures include hospital admissions, and one-year survival. The study is expected to generate valuable evidence about the link between non-invasive ventilation and diaphragm function, which may contribute to optimizing treatment strategies for COPD patients with advanced respiratory failure.

Conditions

  • BIPAP Biphasic Intermittent Positive Airway Pressure
  • Diaphragm Issues
  • Ultrasound Diagnostics
  • COPD (Chronic Obstructive Pulmonary Disease)

Interventions

  • BIPAPDevice

    After BIPAP Prescribed By A Physician, Diaphragmatic Functions Will Be Evaluated With Ultrasound In The Early And Late Periods

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. One-Year SurvivalTime frame: at baseline and after 12 months
  2. Number of Hospital Admissions within 12 MonthsTime frame: at baseline and after 12 months
  3. Maximum Inspiratory Pressure (MIP)Time frame: Baseline, after 6 weeks of BiPAP usage, and after one year

8 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Demiroglu Bilim University, Department of Physiotherapy and Rehabilitation

    Istanbul, Turkey (Türkiye)

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.